The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Open accessAbstract
OBJECTIVES. To systematically review the literature on inborn errors of metabolism, neonatal screening technology and screening programmes in order to analyse the costs and benefits of introducing screening based on tandem mass-spectrometry (tandem MS) for a wide range of disorders of amino acid and organic acid metabolism in the UK. To evaluate screening for cystic fibrosis, Duchenne muscular dystrophy and other disorders which are tested on an individual basis. HOW THE RESEARCH WAS CONDUCTED. Systematic searches were carried out of the literature on inborn errors of metabolism, neonatal screening programmes, tandem MS-based neonatal screening technology, economic evaluations of neonatal screening programmes and psychological aspects of neonatal screening. Background material on the biology of inherited metabolic disease, the basic philosophy, and the history and current status of the UK screening programme was also collected. Relevant papers in the grey literature and recent publications were identified by hand-searching. Each paper was graded. For each disease an aggregate grade for the state of knowledge in six key areas was awarded. Additional data were prospectively collected on activity and costs in UK neonatal screening laboratories, and expert clinical opinion on current treatment modalities and outcomes. These data were used to construct a decision-analysis model of neonatal screening technologies, comparing tandem MS with the existing phenylketonuria screening methods. This model determined the cost per additional case identified and, for each disease, the additional treatment costs per case, and the cost per life-year saved. All costs and benefits were discounted at 6% per annum. One-way sensitivity analysis was performed showing the effect of varying the discount rate, the incidence rate of each disorder, the number of neonates screened and the cost of tandem MS, on the cost per life-year gained. RESEARCH FINDINGS. The UK screening programmes for phenylketonuria and congenital hypothyroidism have largely achieved the expected objectives and are cost-effective. Current concerns are the difficulty of maintaining adequate coverage, perceived organisational weaknesses, and a lack of overview. For many of the organic acid disorders it was necessary to rely on data obtained from clinically-diagnosed cases. Many of these diseases can be treated very effectively and a sensitive screening test was available for most of the diseases. Except for cystic fibrosis, there have been no randomised controlled trials of the overall effectiveness of neonatal screening. Despite the anxiety generated by the screening process, there is strong parental support for screening. The effects of diagnosis through screening on subsequent reproductive behaviour is less clear. Conflicts exist between current concepts and the traditional principles of screening. The availability of effective treatment is not an absolute prerequisite: early diagnosis is of value to the family concerned and, to the extent that is leads to increased use of prenatal diagnosis, may help to reduce the overall burden of disease. Neonatal screening is also of value in diseases which present early but with non-specific symptoms. Indeed, almost all of the diseases considered could merit neonatal screening. The majority of economic evaluations failed to incorporate the health benefits from screening, and therefore failed to address the value of the information which the screening programmes provided to parents. The marginal cost of changing from present technology to tandem MS would be approximately 0.60 pounds per baby at a workload of 100,000 samples a year, and 0.87 pounds at 50,000 samples per year. The ability to screen for a wider range of diseases would lead to the identification of some 20 additional cases per 100,000 infants screened, giving a laboratory cost per additional diagnosis of 3000 pounds at an annual workload of 100,000 babies per year.(ABSTRACT TRUNCATED)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
The Metabolic Basis of Inherited Disease.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-425_3 · Cited by 2,687
A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS
Guthrie, R., & Susi, A. (1963) · Pediatrics · doi:10.1542/peds.32.3.338 · Cited by 2,219
The Metabolic Basis of Inherited Disease
Solomon, L. M. (1979) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12541649 · Cited by 2,070
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
The natural history of homocystinuria due to cystathionine beta-synthase deficiency.
Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B. M., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., & Cerone, R. (1985) · PubMed · Cited by 1,256
Schiff, L., & Schiff, E. R. (1975) · Andalas University Repository (Andalas University) · Cited by 1,142
Pain expression in neonates: facial action and cry
Grunau, R. V. E., & Craig, K. D. (1987) · Pain · doi:10.1016/0304-3959(87)90073-x · Cited by 1,040
Mudd, S. H. (1989) · Medical Entomology and Zoology · Cited by 1,019
Sensory Neuropathy from Pyridoxine Abuse: A New Megavitamin Syndrome
Schaumburg, H., Kaplan, J., Windebank, A., Vick, N., Rasmus, S., Pleasure, D., & Brown, M. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090801 · Cited by 708
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase
LINDSTEDT, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92685-9 · Cited by 631
The Metabolic Basis of Inherited Disease
Gutman, A. B. (1972) · Hospital Practice · doi:10.1080/21548331.1972.11706203 · Cited by 573
Disorders of propionate and methylmalonate metabolism
Chalmers, R. A., & Lawson, A. M. (1982) · Organic Acids in Man · doi:10.1007/978-94-009-5778-7_11 · Cited by 558
Long‐term prognosis in galactosaemia: Results of a survey of 350 cases
Waggoner, D., Buist, N. R. M., & Donnell, G. N. (1989) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800204 · Cited by 535
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
Briggs, A., Sculpher, M., & Buxton, M. (1994) · Health Economics · doi:10.1002/hec.4730030206 · Cited by 521
Highsmith, W. E., Burch, L. H., Zhou, Z., Olsen, J. C., Boat, T. E., Spock, A., Gorvoy, J. D., Quittell, L., Friedman, K. J., Silverman, L. M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311503 · Cited by 441
REACTIONS TO THE THREATENED LOSS OF A CHILD: A VULNERABLE CHILD SYNDROME
Green, M., & Solnit, A. J. (1964) · Pediatrics · doi:10.1542/peds.34.1.58 · Cited by 441
Mitochondrial Fatty-Acid Oxidation Disorders
Kompare, M., & Rizzo, W. B. (2008) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2008.05.008 · Cited by 429
MENKES, J. H., HURST, P. L., & CRAIG, J. M. (1954) · Pediatrics · doi:10.1542/peds.14.5.462 · Cited by 413
Msall, M., Batshaw, M. L., Suss, R., Brusilow, S. W., & Mellits, E. D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406073102304 · Cited by 411
Green, M., & Solnit, A. J. (1964) · PubMed · Cited by 393
Inborn Metabolic Diseases: Diagnosis and Treatment
(2012) · doi:10.1007/978-3-642-15720-2 · Cited by 377
Chace, D. H., Millington, D. S., Terada, N., Kahler, S. G., Roe, C. R., & Hofman, L. F. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.1.66 · Cited by 374
Screening for congenital hypothyroidism: Results of screening one million North American infants
Fisher, D. A., Dussault, J. H., Foley, T. P., Klein, A. H., LaFranchi, S., Larsen, P. R., Mitchell, M. L., Murphey, W. H., & Walfish, P. G. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80133-x · Cited by 372
Techniques in diagnostic human biochemical genetics
Shapira, E. (1991) · Europe PMC (PubMed Central) · Cited by 351
Disorders of Galactose Metabolism
Berry, G. T., Segal, S., & Gitzelmann, R. (2006) · Inborn Metabolic Diseases · doi:10.1007/978-3-540-28785-8_7 · Cited by 323
Disorders of peroxisome biogenesis
Braverman, N., Dodt, G., Gould, S., & Valle, D. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.suppl_1.1791 · Cited by 283
Developmental changes in pain expression in premature, full-term, two- and four-month-old infants
Johnston, C. C., Stevens, B., Craig, K. D., & Grunau, R. V. E. (1993) · Pain · doi:10.1016/0304-3959(93)90132-9 · Cited by 280
Medium–chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children
Iafolla, A. K., Thompson, R. J., & Roe, C. R. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70363-9 · Cited by 274
The Economics of Safety and Physical Risk.
Besley, T., & Jones-Lee, M. W. (1990) · Economica · doi:10.2307/2554944 · Cited by 259
Pain in infancy: Neonatal reaction to a heel lance
Owens, M. E., & Todt, E. H. (1984) · Pain · doi:10.1016/0304-3959(84)90813-3 · Cited by 250
Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to Pyridoxine
Wilcken, D. E. L., Wilcken, B., Dudman, N. P. B., & Tyrrell, P. A. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090802 · Cited by 243
Intelligence and quality of dietary treatment in phenylketonuria.
Smith, I., Beasley, M. G., & Ades, A. E. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.5.472 · Cited by 237
Blood Screening for Phenylketonuria
Guthrie, R. (1961) · JAMA · doi:10.1001/jama.1961.03040470079019 · Cited by 235
Neurologic Crises in Hereditary Tyrosinemia
Mitchell, G., Larochelle, J., Lambert, M., Michaud, J., Grenier, A., Ogier, H., Gauthier, M., Lacroix, J., Vanasse, M., Larbrisseau, A., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220704 · Cited by 232
Long-term outcome in 134 patients with galactosaemia
Schweitzer, S., Shin, Y., Jakobs, C., & Brodehl, J. (1993) · European Journal of Pediatrics · doi:10.1007/bf02072514 · Cited by 230
MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY
Snyderman, S. E., Norton, P. M., Roitman, E., & Holt, L. E. (1964) · Pediatrics · doi:10.1542/peds.34.4.454 · Cited by 226
Pacifying Effects of Nonnutritive Sucking on Term and Preterm Neonates During Heelstick Procedures
Field, T., & Goldson, E. (1984) · Pediatrics · doi:10.1542/peds.74.6.1012 · Cited by 220
Chace, D. H., Hillman, S. L., Millington, D. S., Kahler, S. G., Roe, C. R., & Naylor, E. W. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.62 · Cited by 219
Compas, B. E., Howell, D. C., Phares, V., Williams, R. A., & Giunta, C. T. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.57.6.732 · Cited by 217
Millington, D. S., Norwood, D. L., Kodo, N., Roe, C. R., & Inouet, F. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90441-7 · Cited by 196
Adult Height and Fertility in Men with Congenital Virilizing Adrenal Hyperplasia
Urban, M. D., Lee, P. A., & Migeon, C. J. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812212992505 · Cited by 196
Van Spronsen, F. J., Thomasse, Y., Smit, P. G. A., Leonard, J. V., Clayton, P. T., Fidler, V., Berger, R., & Heymans, H. S. A. (1994) · Hepatology · doi:10.1002/hep.1840200513 · Cited by 193
Gafni, A. (1991) · PubMed · Cited by 190
Kooistra, L., Laane, C., Vulsma, T., Schellekens, J. M. H., van der Meere, J. J., & Kalverboer, A. F. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83178-6 · Cited by 185
Pain-reducing Properties of Sucrose in Human Newborns
Blass, E. M., & Shah, A. (1995) · Chemical Senses · doi:10.1093/chemse/20.1.29 · Cited by 179
Tillotson, S. L., Fuggle, P. W., Smith, I., Ades, A. E., & Grant, D. B. (1994) · BMJ · doi:10.1136/bmj.309.6952.440 · Cited by 177
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.
Hove, J. L. K. V., Zhang, W. Y., Kahler, S. G., Roe, C. R., Chen, Y., Terada, N., Chace, D. H., Iafolla, A. K., Ding, J. H., & Millington, D. S. (1993) · Europe PMC (PubMed Central) · Cited by 176
The analgesic effect of sucrose in full term infants: a randomised controlled trial
Haouari, N., Wood, C., Griffiths, G., & Levene, M. (1995) · BMJ · doi:10.1136/bmj.310.6993.1498 · Cited by 176
THIAMINE-RESPONSIVE MAPLE-SYRUP-URINE DISEASE
Scriver, C. R., Clow, C. L., Mackenzie, S., & Delvin, E. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91041-5 · Cited by 173
Ziadeh, R., Hoffman, E. P., Finegold, D. N., Hoop, R. C., Brackett, J. C., Strauss, A. W., & Naylor, E. W. (1995) · Pediatric Research · doi:10.1203/00006450-199505000-00021 · Cited by 165
Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean.
(1990) · Europe PMC (PubMed Central) · Cited by 163
Klingensmith, G. J., Garcia, S. C., Jones, H. W., Migeon, C. J., & Blizzard, R. M. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80581-7 · Cited by 163
Wilcken, B., Wiley, V., Sherry, G., & Bayliss, U. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70040-4 · Cited by 163
Pang, S., Clark, A., Neto, E. C., Giugliani, R., Dean, H., Winter, J., Dhondt, J.-L., Farriaux, J. P., Graters, A., Cacciari, E., et al. (1993) · Screening · doi:10.1016/0925-6164(93)90024-d · Cited by 161
Bucher, H.-U., Moser, T., Siebenthal, K. V., Keel, M., Wolf, M., & Duc, G. (1995) · Pediatric Research · doi:10.1203/00006450-199509000-00010 · Cited by 160
Chatfield, S., Owen, G., Ryley, H. C., Williams, J., Alfaham, M., Goodchild, M. C., & Weller, P. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.1_spec_no.29 · Cited by 158
Toublanc, J. (2008) · Hormone Research · doi:10.1159/000182549 · Cited by 154
The inborn errors of mitochondrial fatty acid oxidation
Vianey‐Saban, C., Divry, P., Gregersen, N. V., & Mathieu, M. (1987) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01812855 · Cited by 146
Millington, D. S., Kodo, N., Terada, N., et al. (1991) · International Journal of Mass Spectrometry and Ion Processes · doi:10.1016/0168-1176(91)85056-r · Cited by 143
Sepsis Due toEscherichia coliin Neonates with Galactosemia
Levy, H. L., Sepe, S. J., Shih, V. E., Vawter, G. F., & Klein, J. O. (1977) · New England Journal of Medicine · doi:10.1056/nejm197710132971510 · Cited by 143
L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia.
Roe, C. R., Millington, D. S., Maltby, D. A., Bohan, T. P., & Hoppel, C. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111387 · Cited by 142
Prospective treatment of urea cycle disorders
Maestri, N. E., Hauser, E. R., Bartholomew, D., & Brusilow, S. W. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83044-6 · Cited by 142
Dankert-Roelse, J. E., & Meerman, G. J. T. (1995) · Thorax · doi:10.1136/thx.50.7.712 · Cited by 142
Rocking and pacifiers: Two comforting interventions for heelstick pain
Campos, R. G. (1994) · Research in Nursing & Health · doi:10.1002/nur.4770170503 · Cited by 140
Chace, D. H., Hillman, S. L., Millington, D. S., Kahler, S. G., Adam, B. W., & Levy, H. L. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.3.349 · Cited by 136
Alm, J., Hagenfeldt, L., Larsson, A., & Lundberg, K. (1984) · BMJ · doi:10.1136/bmj.289.6453.1171 · Cited by 136
Grompe, M., St.-Louis, M., Demers, S. I., Al-Dhalimy, M., Leclerc, B., & Tanguay, R. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310603 · Cited by 135
Parents?? Knowledge of Neonatal Screening and Response to False-Positive Cystic Fibrosis Testing
Tluczek, A., Mischler, E. H., Farrell, P. M., Fost, N., Peterson, N. M., CAREY, P., Bruns, W. T., & MCCARTHY, C. (1992) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199206000-00005 · Cited by 135
Aetiology of congenital absence of vas deferens: genetic study of three generations
Patrizio, P., Asch, R. H., Handelin, B., & Silber, S. J. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138025 · Cited by 130
Gregg, R. G., Wilfond, B. S., Farrell, P. M., et al. (1993) · PubMed · Cited by 128
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period.
Weaver, L. T., Green, M. R., Nicholson, K., Mills, J. L., Heeley, M. E., Kuzemko, J. A., Austin, S., Gregory, G. A., Dux, A., & Davis, J. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.70.2.84 · Cited by 127
Newborn Screening for Congenital Hypothyroidism
Clause, M. (2013) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2013.03.009 · Cited by 126
ROVET, J. F., Ehrlich, R. M., & Sorbara, D. (1992) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/17.2.187 · Cited by 124
Newborn Screening for Duchenne Muscular Dystrophy
Zellweger, H., & Antonik, A. (1975) · PEDIATRICS · doi:10.1542/peds.55.1.30 · Cited by 123
Sensitivity analysis in economic evaluation: A review of published studies
Briggs, A. H., & Sculpher, M. J. (1995) · Health Economics · doi:10.1002/hec.4730040502 · Cited by 122
CT and MR of the brain in disorders of the propionate and methylmalonate metabolism.
Brismar, J., & Ozand, P. T. (1994) · PubMed · Cited by 121
The use of betaine for the treatment of homocystinuria
Smolin, L. A., Benevenga, N. J., & Berlow, S. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80352-6 · Cited by 118
Sorenson, J. R., Levy, H. L., Mangione, T. W., & Sepe, S. J. (1984) · PEDIATRICS · doi:10.1542/peds.73.2.183 · Cited by 117
Vulnerable Children: Parents' Perspectives and the Use of Medical Care
Levy, J. C. (1980) · PEDIATRICS · doi:10.1542/peds.65.5.956 · Cited by 115
Glorieux, J., Dussault, J. H., & Vliet, G. V. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81150-3 · Cited by 115
Neonatal Screening for Inborn Errors of Metabolism
Bickel, H., Guthrie, R. W., & Hammersen, G. (1980) · Springer eBooks · doi:10.1007/978-3-642-67488-4 · Cited by 113
Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention
Marcus, M., Sondel, S., Farrell, P., et al. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.578 · Cited by 112
Experience with screening newborns for Duchenne muscular dystrophy in Wales.
Bradley, D. M., Parsons, E. P., & Clarke, A. J. (1993) · BMJ · doi:10.1136/bmj.306.6874.357 · Cited by 108
Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency
Bhala, A., Willi, S. M., Rinaldo, P., Bennett, M. J., Schmidt‐Sommerfeld, E., & Hale, D. E. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70207-5 · Cited by 107
Schmidt, E., Rupp, A., Burgard, P., Pietz, J., Weglage, J., & de Sonneville, L. M. J. (1994) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639408402681 · Cited by 107
TIMING OF STRICT DIET IN RELATION TO FETAL DAMAGE IN MATERNAL PHENYLKETONURIA
Drogari, E., Beasley, M., Smith, I., & Lloyd, J. K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91418-8 · Cited by 106
The origin of newborn screening
Guthrie, R. W. (1992) · Screening · doi:10.1016/0925-6164(92)90025-z · Cited by 105
REDUCED MORBIDITY IN PATIENTS WITH CYSTIC FIBROSIS DETECTED BY NEONATAL SCREENING
Wilcken, B. M., & Chalmers, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92623-6 · Cited by 101
LAFRANCHI, S. H., Hanna, C. E., Krainz, P. L., Skeels, M. R., Miyahira, R. S., & Sesser, D. E. (1985) · PEDIATRICS · doi:10.1542/peds.76.5.734 · Cited by 100
Intelligence, motor skills and behaviour at 5 years in early-treated congenital hypothyroidism
Fuggle, P., Grant, D., Smith, I., & Murphy, G. H. (1991) · European Journal of Pediatrics · doi:10.1007/bf02072209 · Cited by 99
Bodegård, G., FYRÖ, K., & Larsson, A. (1983) · Acta Paediatrica · doi:10.1111/j.1651-2227.1983.tb09850.x · Cited by 97
Making heel pricks less painful.
Harpin, V., & Rutter, N. (1983) · Archives of Disease in Childhood · doi:10.1136/adc.58.3.226 · Cited by 93
Robson, M., Abbott, J., Webb, K., Dodd, M. E., & Walsworth-Bell, J. (1992) · Thorax · doi:10.1136/thx.47.9.684 · Cited by 93
Neonatal Hypothyroidism Detected by the Northwest Regional Screening Program
LAFRANCHI, S. H., Murphey, W. H., Foley, T. P., et al. (1979) · PEDIATRICS · doi:10.1542/peds.63.2.180 · Cited by 91
Ranieri, E., Lewis, B. D., Gerace, R., Ryall, R. G., Morris, C. P., Nelson, P. V., Carey, W. F., & Robertson, E. F. (1994) · BMJ · doi:10.1136/bmj.308.6942.1469 · Cited by 90
Grant, D. B., & Smith, I. (1988) · BMJ · doi:10.1136/bmj.296.6633.1355 · Cited by 89
Dietary treatment of homocystinuria.
Komrower, G. M., Lambert, A. M., Cusworth, D. C., & Westall, R. G. (1966) · Archives of Disease in Childhood · doi:10.1136/adc.41.220.666 · Cited by 89
Disorders of mitochondrial long‐chain fatty acid oxidation
Pollitt, R. J. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00710058 · Cited by 87
FYRÖ, K., & Bodegård, G. (1987) · Acta Paediatrica · doi:10.1111/j.1651-2227.1987.tb10424.x · Cited by 87
Successful liver transplantation in babies under 1 year.
Beath, S. V., Brook, G., Kelly, D. A., Cash, A., McMaster, P., Mayer, A. D., & Buckels, J. A. C. (1993) · BMJ · doi:10.1136/bmj.307.6908.825 · Cited by 86
Wilcken, D. E. L., Dudman, N. P. B., & Tyrrell, P. A. (1985) · Metabolism · doi:10.1016/0026-0495(85)90156-8 · Cited by 86
Kent, G. G. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(96)00173-6 · Cited by 83
Normal Sweat Chloride Values Do Not Exclude the Diagnosis of Cystic Fibrosis
Stewart, B. A., Zabner, J., Shuber, A. P., et al. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/151.3_pt_1.899 · Cited by 83
A survey to evaluate parental consent as public policy for neonatal screening.
Faden, R., Chwalow, A. J., Holtzman, N. A., & Horn, S. D. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1347 · Cited by 82
Cystic fibrosis in the United Kingdom, 1968–1988: incidence, population and survival
Dodge, J. A., Morison, S., Lewist, P. A., Coles, E. C., Geddes, D. M., Russell, G., Jackson, A. D., & Bentley, B. (1993) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.1993.tb00390.x · Cited by 81
Migeon, C. J., Kenney, F. M., Richards, C., & Lawrence, B. (1966) · The Journal of Pediatrics · doi:10.1016/s0022-3476(66)80124-5 · Cited by 80
The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH)
DiMartino-Nardi, J., Stoner, E., O'Connell, A., & New, M. I. (1986) · European Journal of Endocrinology · doi:10.1530/acta.0.112s305 · Cited by 79
Normal Sweat Chloride Values Do Not Exclude the Diagnosis of Cystic Fibrosis
Pignatti, P. F., & Luisetti, M. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.5.7582320 · Cited by 77
Newborn screening for congenital adrenal hyperplasia in New Zealand
Cutfield, W. S., & WEBSTER, D. R. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70513-9 · Cited by 77
Ranieri, E., Ryall, R. G., Morris, C. P., Nelson, P. V., Carey, W. F., Pollard, A. C., & Robertson, E. F. (1991) · BMJ · doi:10.1136/bmj.302.6787.1237 · Cited by 76
Waisbren, S., Brown, M., de Sonneville, L. M. J., & Levy, H. L. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13464.x · Cited by 75
Grenier, A., Lescault, A., Laberge, C., Gagné, R., & Marner, O. (1982) · Clinica Chimica Acta · doi:10.1016/0009-8981(82)90117-6 · Cited by 73
Newborn Screening for Maple Syrup Urine Disease (Branched-Chain Ketoaciduria)
Naylor, E. (1980) · Springer eBooks · doi:10.1007/978-3-642-67488-4_3 · Cited by 73
Intellectual development at 10 years in early treated congenital hypothyroidism.
Simons, W. F., Fuggle, P., Grant, D., & Smith, I. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.3.232 · Cited by 73
Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis
Al-Jader, L. N., GOODCHILD, M. C., Ryley, H. C., & Harper, P. S. (1990) · Clinical Genetics · doi:10.1111/j.1399-0004.1990.tb03613.x · Cited by 70
Gregersen, N., Winter, V., Curtis, D., Deufel, T., Mack, M., Hendrickx, J., Willems, P. J., Ponzone, A., Parrella, T., Ponzone, R., et al. (1993) · Human Heredity · doi:10.1159/000154157 · Cited by 70
Psychological impact of false-positive results when screening for cystic fibrosis
Tluczek, A., Mischler, E. H., Bowers, B. J., Peterson, N. M., Morris, M. E., Farrell, P. M., Bruns, W. T., Colby, H., McCarthy, C., Fost, N., et al. (1991) · Pediatric Pulmonology · doi:10.1002/ppul.1950110707 · Cited by 69
Newborn screening for cystic fibrosis: Its evolution and a review of the current situation
Wilcken, B. M. (1993) · Screening · doi:10.1016/0925-6164(93)90017-d · Cited by 68
Newborn screening by tandem mass spectrometry (MS-MS)
Sweetman, L. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.3.345 · Cited by 67
Population screening for congenital hypothyroidism.
Hulse, J. A., Grant, D., Clayton, B. E., Lilly, P., Jackson, D., Spracklan, A., Edwards, R. W., & Nurse, D. (1980) · BMJ · doi:10.1136/bmj.280.6215.675 · Cited by 65
'Quick and clean': authoritative health technology assessment for local health care contracting.
Stevens, A. J., Colin-Jones, D. G., & Gabbay, J. (1995) · PubMed · Cited by 64
Screening for Congenital Hypothyroidism
Henry, G., Sobki, S. H., & Othman, J. M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92073-7 · Cited by 62
Tymstra, T. (1986) · Family Practice · doi:10.1093/fampra/3.2.92 · Cited by 62
Cunnah, D., Perry, L., DACIE, J. A., Grant, D., Lowe, D., Savage, M. O., & BESSER, G. M. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb03735.x · Cited by 62
Electrospray tandem mass spectrometry in the diagnosis of organic acidemias
Rashed, M. S., Ozand, P. T., Harrison, M. E., et al. (1994) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1290080124 · Cited by 62
Newborn Screening for Maple Syrup Urine Disease (Branched-Chain Ketoaciduria)
Naylor, E. W., & Guthrie, R. W. (1978) · PEDIATRICS · doi:10.1542/peds.61.2.262 · Cited by 62
Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency
Donaldson, M. D., Thomas, P. H., Love, J. G., Murray, G. D., McNinch, A. W., & Savage, D. C. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.70.3.214 · Cited by 60
Outcome of maple syrup urine disease.
Naughten, E. R., Jenkins, J. A., Francis, D. E. M., et al. (1982) · Archives of Disease in Childhood · doi:10.1136/adc.57.12.918 · Cited by 59
Price, D. A., Ehrlich, R. M., & Walfish, P. G. (1981) · Archives of Disease in Childhood · doi:10.1136/adc.56.11.845 · Cited by 58
Treatment of inherited metabolic disorders by liver transplantation
Burdelski, M. M., Rodeck, B., Latta, A., Latta, K., Brodehl, J., Ringe, B., & Pichlmayr, R. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01797930 · Cited by 56
Evers‐Kiebooms, G., Denayer, L., & den Berghe, H. V. (1990) · Clinical Genetics · doi:10.1111/j.1399-0004.1990.tb03504.x · Cited by 54
Congenital Adrenal Hyperplasia
Doneva, V., Sadikario, A., Zdraveva, M., Vlaški, J., & Grozdanov, L. (2017) · American Academy of Pediatrics eBooks · doi:10.1542/9781610020862-part02-congenital · Cited by 52
Disclosure of Duchenne muscular dystrophy after newborn screening.
Parsons, E. P., Bradley, D. M., & Clarke, A. J. (1996) · Archives of Disease in Childhood · doi:10.1136/adc.74.6.550 · Cited by 50
Intelligence in mild atypical phenylketonuria
Costello, P. M., Beasley, M. G., Tillotson, S. L., & Smith, I. (1994) · European Journal of Pediatrics · doi:10.1007/bf01954515 · Cited by 49
Wallace, A. M., Beastall, G. H., Cook, B., Currie, A., Ross, A. M., Kennedy, R., & Girdwood, R. W. A. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1080299 · Cited by 49
Monitoring treatment in congenital adrenal hyperplasia.
Appan, S., Hindmarsh, P. C., & Brook, C. G. D. (1989) · Archives of Disease in Childhood · doi:10.1136/adc.64.9.1235 · Cited by 48
Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history.
Green, M. R., Weaver, L. T., Heeley, A. F., et al. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.4.464 · Cited by 47
Early Liver Transplantation Is Indicated for Tyrosinemia Type I
Freese, D. K., Tuchman, M., Schwarzenberg, S. J., Sharp, H. L., Rank, J. M., Bloomer, J. R., Ascher, N. L., & Payne, W. D. (1991) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199107000-00002 · Cited by 45
Dhondt, J., Farriaux, J. P., Sailly, J.-C., & Lebrun, T. C. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01797933 · Cited by 45
Jakobs, C., DORLAND, L., Wikkerink, B., Kok, R. M., de Jong, A. P. J. M., & Wadman, S. K. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90147-7 · Cited by 43
Vulnerable Child Syndrome and Its Variants
Green, M. (1986) · Pediatrics in Review · doi:10.1542/pir.8-3-75 · Cited by 43
SUBTLE SPEECH AND MOTOR DEFICITS OF CHILDREN WITH CONGENITAL ‘ HYPOTHYROID TREATED EARLY
Gottschalk, B., Richman, R. A., & Lewandowski, L. J. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11834.x · Cited by 43
Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group.
Pm, F., & Eh, M. (1992) · PubMed · Cited by 43
Evoked Potentials and Electroencephalography in Adolescents with Phenylketonuria
Korinthenberg, R., Ullrich, K., & Füllenkemper, F. (1988) · Neuropediatrics · doi:10.1055/s-2008-1052440 · Cited by 42
3‐Hydroxyisovalerylcarnitine in 3‐methylcrotonyl‐CoA carboxylase deficiency
Hove, J. L. K. V., Rutledge, S. L., Nada, M. A. R., Kahler, S. G., & Millington, D. S. (1994) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02436004 · Cited by 42
Screening for Duchenne muscular dystrophy.
Fenton‐May, J., Bradley, D. M., Sibert, J. R., Smith, R., Parsons, E. P., Harper, P. S., & Clarke, A. J. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.70.6.551 · Cited by 41
The impact of newborn screening on cystic fibrosis testing in Victoria, Australia.
Balnaves, M. E., Bonacquisto, L., Francis, I., et al. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.7.537 · Cited by 41
Combined vitamin responsiveness in homocystinuria
Morrow, G., & Barness, L. A. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80548-1 · Cited by 40
Branched Chain Amino and Keto Acids in Health and Disease
Chalmers, R. A. (1986) · Journal of Medical Genetics · doi:10.1136/jmg.23.3.283-a · Cited by 39
Should we screen for congenital adrenal hyperplasia? A review of 117 cases.
Virdi, N. K., RAYNER, P. H. W., Rudd, B. T., & Green, A. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.7.659 · Cited by 37
Cystic fibrosis mutation analysis: Report from 22 U.K. regional genetics laboratories
Schwarz, M. J., Malone, G., Haworth, A., Cheadle, J. P., Meredith, A. L., Gardner, A., Sawyer, I. H., Connarty, M., Dennis, N. R., Seller, A., et al. (1995) · Human Mutation · doi:10.1002/humu.1380060406 · Cited by 37
PROGRESS REPORT 1980 ON NEONATAL THYROID SCREENING IN EUROPE
Delange, F. M., ILLIG, R., ROCHICCIOLI, P. E., et al. (1981) · Acta Paediatrica · doi:10.1111/j.1651-2227.1981.tb07163.x · Cited by 37
Millington, D. S., Roe, C. R., & Maltby, D. A. (1987) · Journal of Mass Spectrometry · doi:10.1002/bms.1200141204 · Cited by 36
Effects of newborn screening of cystic fibrosis on reported maternal behaviour.
Boland, C., & Thompson, N. L. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.11.1240 · Cited by 36
Congenital Hypothyroidism Control Programs
Layde, P. M. (1979) · JAMA · doi:10.1001/jama.241.21.2290 · Cited by 36
Aetiology of Congenital Hypothyroidism in Finland
Virtanen, M. A., Mäenpää, J., Pikkarainen, J., et al. (1989) · Acta Paediatrica · doi:10.1111/j.1651-2227.1989.tb10889.x · Cited by 35
Developmental profile of patients with maple syrup urine disease
Nord, A. M., van Doorninck, W. J., & Greene, C. L. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800467 · Cited by 34
Growth Follow-up in 100 Children with Congenital Hypothyroidism Before and During Treatment
Chiesa, A. E., de Papendieck, L. G., Keselman, A. C., Heinrich, J. J., & Bergadá, C. (1994) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1994.7.3.211 · Cited by 34
Diagnostic Dilemmas: Results of Screening Tests for Congenital Hypothyroidism
Willi, S. M., & Moshang, T. (1991) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38117-2 · Cited by 34
ROCHICCIOLI, P. E., eacute, B. R., Alexandre, F., & Tauber, M. (2008) · Hormone Research · doi:10.1159/000182550 · Cited by 33
Hematin therapy for the neurologic crisis of tyrosinemia
Rank, J. M., Pascual‐Leone, Á., Payne, W. D., Glock, M. S., Freese, D. K., Sharp, H. L., & Bloomer, J. R. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81867-0 · Cited by 32
Parental attitudes toward newborn screening for cystic fibrosis
Helton, J. L., Harmon, R. J., Robinson, N., & Accurso, F. J. (1991) · Pediatric Pulmonology · doi:10.1002/ppul.1950110706 · Cited by 32
Schmidt‐Sommerfeld, E., Penn, D., Durán, M., Bennett, M. J., Santer, R., & Stanley, C. A. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(06)80009-0 · Cited by 31
Longitudinal assessment of children with congenital hypothyroidism detected by neonatal screening.
Moschini, L., Costa, P., Marinelli, E., Maggioni, G., Sorcini, M., Fazzini, C., Diodato, A. M., Sabini, G., Me, G., & Carta, S. (1986) · PubMed · Cited by 31
Segal, S. (1995) · European Journal of Pediatrics · doi:10.1007/bf02143813 · Cited by 31
Cost-Benefit Analysis of Newborn Screening for Metabolic Disorders
(1974) · New England Journal of Medicine · doi:10.1056/nejm197412262912614 · Cited by 30
Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I.
Laberge, C. M., Grenier, A., Valet, J. P., & Morissette, J. (1990) · Europe PMC (PubMed Central) · Cited by 29
Gibbs, T., Payan, J., Brett, E. M., Lindstedt, S., Holme, E., & Clayton, P. T. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.10.1129 · Cited by 29
Inborn errors of urea synthesis
Brusilow, S. W. (1985) · Elsevier eBooks · doi:10.1016/b978-0-407-02312-3.50012-0 · Cited by 28
Acute pancreatitis in propionic acidaemia
Burlina, A., Dionisi‐Vici, C., Piovan, S., Saponara, I., Bartuli, A., Sabetta, G., & Zacchello, F. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711758 · Cited by 28
Shoemaker, L. R., Strife, C. F., Balistreri, W. F., & Ryckman, F. C. (1992) · PEDIATRICS · doi:10.1542/peds.89.2.251 · Cited by 28
Rasat, R., Espiner, E. A., & Abbott, G. D. (1995) · PubMed · Cited by 26
Tein, I., Donner, E. J., Hale, D. E., & Murphy, E. G. (1995) · Pediatric Neurology · doi:10.1016/0887-8994(94)00109-f · Cited by 26
Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy.
Hildes, E., Jacobs, H. K., Cameron, A., Seshia, S. S., Booth, F. A., Evans, J. A., Wrogemann, K., & Greenberg, C. R. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.8.670 · Cited by 26
Neonatal screening for muscular dystrophy
van Ommen, G. J. B., & Scheuerbrandt, G. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90065-r · Cited by 26
Mothers' consent to screening newborn babies for disease.
Statham, H., Green, J., & Snowdon, C. (1993) · BMJ · doi:10.1136/bmj.306.6881.858-c · Cited by 26
Ohkubo, S., Shimozawa, K., Matsumoto, M., & Kitagawa, T. (1992) · PubMed · Cited by 25
Larsson, A., Hagenfeldt, L., von Döbeln, U., Curstedt, T., Gustafsson, J., & Svensson, E. (2008) · Hormone Research · doi:10.1159/000181069 · Cited by 25
Sometimes sensitive, seldom specific: A review of the economics of screening
Cairns, J., & Shackley, P. (1993) · Health Economics · doi:10.1002/hec.4730020106 · Cited by 25
Difficulties in Psychological Adjustment to a New Neonatal Screening Programme
FYRÖ, K., & Bodegård, G. (1988) · Acta Paediatrica · doi:10.1111/j.1651-2227.1988.tb10634.x · Cited by 25
The costs and benefits of screening for PKU in Wisconsin
Barden, H. S., Kessel, R., & Schuett, V. E. (1984) · Biodemography and Social Biology · doi:10.1080/19485565.1984.9988558 · Cited by 25
Einaudi, S., Lala, R., Corrias, A., Matarazzo, P., Pagliardini, S., & De Sanctis, C. (1993) · PubMed · Cited by 25
Homocystinuria (cystathionine synthase deficiency). Results of treatment in late-diagnosed patients
Gr�be, H. (1980) · European Journal of Pediatrics · doi:10.1007/bf00441642 · Cited by 24
de Zegher, F., Vanderschueren‐Lodeweyckx, M., Heinrichs, C., et al. (1992) · Acta Paediatrica · doi:10.1111/j.1651-2227.1992.tb12223.x · Cited by 24
Dündar, M., Lanyon, W. G., & Connor, J. M. (1993) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711516 · Cited by 24
Screening for tyrosinaemia type I.
Hutchesson, A. C. J., Hall, S. K., Preece, M. A., & Green, A. (1996) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.74.3.f191 · Cited by 24
Carnitine and Acylcarnitines in Metabolic Disease Diagnosis and Management
Millington, D. S., & Chace, D. H. (1992) · Springer eBooks · doi:10.1007/978-1-4899-1173-5_8 · Cited by 23
Most cases of medium-chain acyl-CoA dehydrogenase deficiency escape detection in France
Fromenty, B., Mansouri, A., Bonnefont, J., Courtois, F., Münnich, A., Rabier, D., & Pessayre, D. (1996) · Human Genetics · doi:10.1007/bf02185775 · Cited by 23
A cost-benefit analysis of the Quebec network of genetic medicine
Dagenais, D. L., Courville, L., & Dagenais, M. G. (1985) · Social Science & Medicine · doi:10.1016/0277-9536(85)90399-5 · Cited by 23
Nutrition support for glutaric acidemia type I
Yannicelli, S., Rohr, F., & Warman, M. L. (1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)90245-3 · Cited by 22
DUCHENNE MUSCULAR DYSTROPHY: NEONATAL SCREENING AND PRENATAL DIAGNOSIS
Plauchu, H., Dorche, C., Cordier, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92170-3 · Cited by 22
No sensory neuropathy during pyridoxine treatment in homocystinuria.
Mpofu, C., Alani, S. M., Whitehouse, C., Fowler, B., & Wraith, J. E. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.9.1081 · Cited by 21
Larsen, J., Campbell, S., Faragher, E. B., et al. (1994) · European Journal of Pediatrics · doi:10.1007/bf02190660 · Cited by 21
Liver transplantation in nine Spanish patients with tyrosinaemia type I
Pérez‐Cerdá, C., Merinero, B., Sanz, P., Castro, M., Gangoiti, J. A., García, M. J., Díaz, M., Medina, E. M. E., & Ugarte, M. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711744 · Cited by 20
Health Economic Analysis of the Neonatal Screening Program in Japan
Hisashige, A. (1994) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300006620 · Cited by 20
Screening for Disorders of Tyrosine Metabolism
Halvorsen, S. (1980) · Springer eBooks · doi:10.1007/978-3-642-67488-4_5 · Cited by 19
Cited by
Shevell, M., Ashwal, S., Donley, D., Flint, J., Gingold, M., Hirtz, D., Majnemer, A., Noetzel, M., & Sheth, R. D. (2003) · Neurology · doi:10.1212/01.wnl.0000031431.81555.16 · Cited by 829
Development and validation of methods for assessing the quality of diagnostic accuracy studies
Whiting, P., Rutjes, A., Dinnes, J., Reitsma, J., Bossuyt, P., & Kleijnen, J. (2004) · Health Technology Assessment · doi:10.3310/hta8250 · Cited by 372
Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review
Green, J., Hewison, J., Bekker, H., Bryant, L., & Cuckle, H. (2004) · Health Technology Assessment · doi:10.3310/hta8330 · Cited by 368
Chace, D. H., Kalas, T. A., & Naylor, E. W. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103213 · Cited by 210
How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?
Grosse, S. D., & Van Vliet, G. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098400 · Cited by 102
Metadata
- Authors
- Pollitt, Green, McCabe, Booth, Cooper, Leonard, Nicholl, Nicholson, Tunaley, & Virdi
- Venue
- Health Technology Assessment
- Published
- 1997
- Volume
- 1
- Issue
- 7
- Pages
- i-iv, 1
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2137680310
- Cited by
- 267
- References
- 222
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.